NCT03275844

Brief Summary

Congenital malformations correspond to defects in organ morphogenesis identifiable at birth or intrauterine life, affecting 2-3% of births. Inside of these malformations, Congenital Heart Disease corresponds, in particular, to structural defects of the heart or major blood vessels thereof may or may not be associated with other types of syndromes.The resolution is usually surgical. Also, these patients present a decrease in physical fitness, psychological imbalance, lower quality of life and risk significant morbidity and mortality from respiratory infections among other problems. This can have severe consequences for health in the medium and long term. The habits acquired during childhood and adolescence are determinant for the adult life, being relevant levels of activity and physical condition, especially in children with pathologies. In this way, it is vital to know from childhood parameters that indicate the baseline state of these patients according to the levels of physical activity, exercise capacity, nutritional status and quality of life. These will be key indicators to take into account in the future, to adapt rehabilitation plans that will reduce the effects of their condition. The objective of this protocol is To characterize the levels of Activity, and Physical Capacity of children with congenital heart disease regularly treated at the Cardiovascular Center of Dr. Luis Hospital Calvo Mackenna, compared to healthy children matched by age and sex.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
17

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2017

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 8, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

September 8, 2017

Status Verified

September 1, 2017

Enrollment Period

4 months

First QC Date

September 5, 2017

Last Update Submit

September 5, 2017

Conditions

Keywords

Physical activityPhysical capacityChildren

Outcome Measures

Primary Outcomes (1)

  • Moderate-to-vigorous physical activity

    Time in minutes of Moderate-to-vigorous physical activity

    1 week

Secondary Outcomes (2)

  • Six minute walking test

    1 hour

  • Steps

    1 week

Study Arms (2)

Group 1

Children with congenital heart disease

Procedure: Physical activity assessment

Group 2

Control healthy subjects

Procedure: Physical activity assessment

Interventions

Assessment of Moderate-to-vigorous physical activity

Group 1Group 2

Eligibility Criteria

Age6 Years - 15 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children with congenital heart diseases

You may qualify if:

  • Children with Tetralogy of Fallot corrected
  • Age from 6 to 15 years
  • Assistants to periodic control at HLCM Cardiovascular Center

You may not qualify if:

  • Morbid obesity
  • Musculoskeletal disorders that impede physical activity
  • Neurological comorbidity
  • Respiratory comorbidity in the last 30 days.
  • Pacemaker users

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart Defects, CongenitalTetralogy of FallotMotor Activity

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBehavior

Study Officials

  • Homero Puppo, MSc

    Univeridad de Chile

    STUDY CHAIR

Central Study Contacts

Roberto M Acosta, MSc

CONTACT

Rodrigo Torres, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 5, 2017

First Posted

September 8, 2017

Study Start

November 1, 2017

Primary Completion

March 1, 2018

Study Completion

September 1, 2018

Last Updated

September 8, 2017

Record last verified: 2017-09